SCHEMBL3820183

SCHEMBL3820183

N#Cc1ccc(N(Cc2ccc(OC(F)(F)F)c(Cl)c2)C2CCNCC2)nn1

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.36
SLC6A2 P23975 5/20 0.35
SLC6A4 P31645 5/20 0.35
SLC6A3 Q01959 4/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
NOS2 P35228 3/20 0.35
CCR5 P51681 1/20 0.34
PANK3 Q9H999 1/20 0.34
GRIN2B Q13224 3/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
KDM1A O60341 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3824402 0.80 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3NOS2KDM1A
SCHEMBL3821207 0.80 SLC6A2 (0.38) CTSLSLC6A2SLC6A4SLC6A3PANK3
SCHEMBL3814247 0.80 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3NOS2
SCHEMBL3820758 0.80 SLC6A2 (0.40) CTSLSLC6A2SLC6A4SLC6A3NOS2
SCHEMBL3818198 0.80 NOS2 (0.47) SLC6A2SLC6A4SLC6A3NOS2NOS3
SCHEMBL3818638 0.77 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3NOS2NOS3
SCHEMBL3821333 0.76 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3NOS2PANK3
SCHEMBL3823147 0.76 TACR1 (0.44) SLC6A2SLC6A4SLC6A3
SCHEMBL3818883 0.76 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3NOS2
SCHEMBL2819867 0.67 DRD2 (0.49) HCRTR1HCRTR2PANK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091938-A1 PIPERIDINYLAMINO-PYRIDAZINES AND THEIR USE AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-08-26 EP disclosed
WO-2008068277-A1 PIPERIDINYLAMINO-PYRIDAZINES AND THEIR USE AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-06-12 WO disclosed